Tips That Can Help Manage Your Ozempic Side Effects

#Ozempic #Wegovy #GLP1 #WeightLoss #obesitymedicine Nausea, constipation, bloating, gas — if you're on semaglutide (Ozempic or Wegovy), gastrointestinal side effects are the most common thing you'll run into. In this video, I break down exactly why they happen and the specific, evidence-based strategies that actually reduce them: portion sizes, meal timing, which foods make it worse, hydration, injection timing, dose titration, and the red flags that mean it's time to call your doctor — not internet folklore, actual clinical data and two decades of hospital medicine.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health CommunityLive Q&As, evidence-based education, accountability, workouts, nutrition guidance & community support.https://www.skool.com/metabolic-health-community-5316TIMESTAMPS0:00 – Intro & Disclaimer1:35 – What Semaglutide Actually Is (and Why Side Effects Happen)3:22 – Tip 1: Cut Your Portions5:14 – Tip 2: Smaller, More Frequent Meals6:27 – Tip 3: Foods That Work Against You8:04 – Tip 4: Hydration & Constipation9:04 – Tip 5: Time Your Injection Around Your Life9:45 – Tip 6: Injection Site — Myth vs. Evidence11:38 – Tip 7: Titration Schedule12:34 – The Symptom Timeline: When It Gets Better13:35 – When to Call Your Doctor14:39 – The Bigger Picture16:01 – Resources & Next StepsWilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002. — https://www.nejm.org/doi/full/10.1056/NEJMoa2032183Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, Pedersen SD. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgraduate Medicine. 2022;134(1):14-19. — https://www.tandfonline.com/doi/full/10.1080/00325481.2021.2002616Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025. — https://ajcn.nutrition.org/article/S0002-9165(25)00240-0/fulltextSaha B, Kamalumpundi V, Codipilly DC. GLP1 and GIP Receptor Agonists: Effects on the Gastrointestinal Tract and Management Strategies for Primary Care Physicians. Mayo Clinic Proceedings. 2025. — https://www.mayoclinicproceedings.org/article/S0025-6196(25)00551-8/fulltextNovo Nordisk. Ozempic (semaglutide) injection Prescribing Information. — https://www.novo-pi.com/ozempic.pdfNovo Nordisk. Wegovy (semaglutide) injection Prescribing Information. — https://www.novo-pi.com/wegovy.pdfFDA Clinical Pharmacology Review, NDA 215866 (tirzepatide) — injection site bioequivalence data, cited in the corrected Tip 6. — https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215866Orig1s000ClinPharmR.pdf⚕️ MEDICAL & EDUCATIONAL DISCLAIMERThis channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.